SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-20-000027
Filing Date
2020-04-30
Accepted
2020-04-30 16:06:51
Documents
16
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-2020331form8xk.htm   iXBRL 8-K 61956
2 EX-99.1 amgn-2020331xq1ex991.htm EX-99.1 563528
8 GRAPHIC amgenlogoa14.jpg GRAPHIC 6206
  Complete submission text file 0000318154-20-000027.txt   876189

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20200430.xsd EX-101.SCH 5186
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20200430_cal.xml EX-101.CAL 638
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20200430_def.xml EX-101.DEF 17999
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20200430_lab.xml EX-101.LAB 38962
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20200430_pre.xml EX-101.PRE 19607
16 EXTRACTED XBRL INSTANCE DOCUMENT amgn-2020331form8xk_htm.xml XML 8725
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 20835667
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences